![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif)
Tuberculosis in the Homeless
David M. Barclay III, MD, MPH;
James P. Richardson, MD;
Lisa Fredman, PhD
Arch Fam Med. 1995;4(6):541-546.
References Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) | ![](/ServeContent?url=http%3A%2F%2Farchfami.ama-assn.org%2Ficons%2Fspacer.gif) |
1. Centers for Disease Control and Prevention. Tuberculosis Statistics in the United States, 1988. Atlanta, Ga: US Dept of Health and Human Services; 1990.
2. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE Jr. Tuberculosis in the United States. JAMA. 1989;262:385-389.
FREE FULL TEXT
3. Snider DE Jr, Slina L, Kelly GD. Tuberculosis: an increasing problem among minorities in the United States. Public Health Rep. 1989;104:646-652.
PUBMED
4. Snider DE Jr, Hutton MD. Tuberculosis in correctional institutions. JAMA. 1989;261:436-437.
FREE FULL TEXT
5. Centers for Disease Control and Prevention. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1989;38:236-238, 243-250.
PUBMED
6. Scheffelbein CW, Snider DE. Tuberculosis control among homeless populations. Arch Intern Med. 1988;148:1843-1846.
FREE FULL TEXT
7. Slutkin G. Management of tuberculosis in urban homeless indigents. Public Health Rep. 1986;101:481-485.
PUBMED
8. Sherman MN, Brickner PW, Schwartz MS, et al. Tuberculosis in a single room occupancy hotel residents: a persisting focus of disease. N Y Med Q. Fall 1980;Z:39-41. 9. Centers for Disease Control and Prevention. Perspectives in disease prevention and health promotion: tuberculosis control among homeless populations, Boston. MMWR Morb Mortal Wkly Rep. 1987;36:257-260.
PUBMED
10. A Report to the Secretary on the Homeless and Emergency Shelters. Washington, DC: Office of Policy Development and Research, US Dept of Housing and Urban Development; 1984. Report PDR 1011. 11. Homes ME, Snyder M. Homeless in America: A Forced March to Nowhere. Washington, DC: Community for Creative Non-Violence; 1982. 12. Hearings Before the House Subcommittee on Housing and Urban Development of the Committee on Banking, Finance and Urban Affairs, 99th Cong, 1st Sess (1985) (testimony of D. E. Altman). 13. Burt MR, Cohen BE. America's Homeless: Characteristics and Programs That Serve Them. Washington, DC: Urban Institute Press; 1989. Report 89-3. 14. Wright JD. Poor people, poor health: the health status of the homeless. J Soc Issues. Winter 1990;46:49-64.
15. Nolan CM, Elarth AM, Barr HA, et al. An outbreak of tuberculosis in a shelter for homeless men: a description of its evolution and control. Am Rev Respir Dis. 1991;143:257-261.
PUBMED
16. Slutkin G, McAdam JM, Brickner PW, Scharger LL, et al. The spectrum of tuberculosis in a New York City men's shelter clinic (1982-1988). Chest. 1990;97:798-805.
PUBMED
17. Torres RA, Sridhar M, Altholz J, Brickner PW. Human immunodeficiency virus infection among homeless men in a New York City shelter: association with mycobacterium tuberculosis infection. Arch Intern Med. 1990;150:2030-2036.
FREE FULL TEXT
18. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745-749.
PUBMED
19. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new factor for tuberculosis disease. Arch Intern Med. 1979;139:337-339.
FREE FULL TEXT
20. Pablos-Mendez A, Raviglione MC, Battan R, Ramos-Zuniga R. Drug resistant tuberculosis among the homeless in New York City. N Y State J Med. 1990;90:351-355.
PUBMED
21. Barry MA, Wall C, Shirley L, et al. Tuberculosis screening in Boston's homeless shelters. Public Health Rep. 1986;101:487-494.
PUBMED
22. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis. 1992;146:1623-1633.
PUBMED
23. Rieder HL, Cauthern GM, Comstock GW, Snider DE. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989;11:79-98.
FREE FULL TEXT
24. Daniel TM. Tuberculosis. In: Wilson JD, Braunwal E, Isselbacher KJ, et al, eds. Harrison's Principals of Internal Medicine. New York, NY: McGraw-Hill International Book Co Inc; 1991: 637-645. 25. Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis. 1967;95:729-745.
PUBMED
26. Nardell E, Mclnnis B, Thomas B, Weidhaas S. Exogenous reinfection with tuberculosis in a shelter for the homeless. N Engl J Med. 1986;315:1570-1575.
ABSTRACT
27. Nardell EA. Beyond four drugs: public health policy and the treatment of the individual patient with tuberculosis. Am Rev Respir Dis. 1993;148:2-5.
PUBMED
28. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco: a population based study using conventional and molecular methods. N Engl J Med. 1994;330:1703-1709.
FREE FULL TEXT
29. Alland DA, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiolgical methods. N Engl J Med. 1994;330:1710-1716.
FREE FULL TEXT
30. Dwyer B, Jackson K, Raios K, Sievers A, Wilshire E, Ross B. DNA restriction fragment analysis to define an extended cluster of tuberculosis in homeless men and their associates. J Infect Dis. 1993;167:490-494.
PUBMED
31. Pitchenik AE, Cole C, Russel BW, Fischl MA, Spira TJ, Snider DE Jr. Tuberculosis, atypical mycobacteriosis, and the acquired immunodeficiency syndrome among Haitian and non-Haitian patients in South Florida. Ann Intern Med. 1984;101:641-645.
PUBMED
32. Centers for Disease Control and Prevention. Tuberculosis and acquired immunodeficiency syndrome: Florida, Boston. MMWR Morb Mortal Wkly Rep. 1986;35:587-590.
PUBMED
33. Sunderam G, McDonald RJ, Maniatis T, Oleske J, Kapila R, Reichman LB. Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA. 1986;256:362-366.
FREE FULL TEXT
34. Centers for Disease Control and Prevention. Tuberculosis and AIDS—Connecticut, Boston. MMWR Morb Mortal Wkly Rep. 1987;36:133-135.
PUBMED
35. Centers for Disease Control and Prevention. Tuberculosis and the acquired immunodeficiency syndrome—New York City, Boston. MMWR Morb Mortal Wkly Rep. 1988;36:785-795.
36. Leff D, Leff A. Tuberculosis control policies in major metropolitan health departments in the United States. Am Rev Respir Dis. 1988;139:1350-1355.
37. Kopaenoff DE, Kilburne JO, Glassroth JL, Snider DE, Farer LS, Good RC. A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977: a United States Public Health Service Cooperation Study. Am Rev Respir Dis. 1978;118:835-842.
PUBMED
38. Centers for Disease Control and Prevention. Primary resistance to anti-tuberculosis drugs— United States, Boston. MMWR Morb Mortal Wkly Rep. 1983;32:521-523.
PUBMED
39. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug resistant tuberculosis in New York City. N Engl J Med. 1993;328:521-526.
FREE FULL TEXT
40. Hobby GL, Johnson PM, Lenert TF, et al. A continuing study of primary drug resistance in tuberculosis in a veteran population within the United States. Am Rev Respir Dis. 1964;89:337-349.
PUBMED
41. Doster B, Caras GJ, Snider DE Jr. A continuing survey of primary drug resistance in tuberculosis, 1961 to 1968: a US Public Health Service Cooperative Study. Am Rev Respir Dis. 1976;113:419-425.
PUBMED
42. Centers for Disease Control and Prevention. Primary resistance to antituberculosis drugs— United States. MMWR Morb Mortal Wkly Rep. 1983;32:521-523.
PUBMED
43. Zaki MH, Lyons HA, Tizes R. The trend of infection with drug resistant strains of Mycobacterium tuberculosis among untreated patients. Am J Public Health. 1969;59:2056-2066.
FREE FULL TEXT
44. Davidson PT. Drug resistance and the selection of therapy for tuberculosis. Am Rev Respir Dis. 1987;136:255-257.
PUBMED
45. Barnes PF. The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis. 1987;136:325-328.
PUBMED
46. Etzkorn ET, Lillis PK, McAllister CK. Tuberculosis in Korea: the relationship between prior therapy and drug resistance. Chest. 1986;90:247-250.
PUBMED
47. Centers for Disease Control and Prevention. A strategic plan for the elimination of tuberculosis in the United States—Boston. MMWR Morb Mortal Wkly Rep. 1989;38:269-272.
PUBMED
48. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculosis infection in high risk populations and the use of preventive therapy for tuberculosis infection in the United States-Boston. MMWR Morb Mortal Wkly Rep. 1990;39(RR-8):1-12.
PUBMED
49. Centers for Disease Control and Prevention. Prevention and control of tuberculosis among homeless persons. MMWR Morb Mortal Wkly Rep. 1992;41:13-21.
PUBMED
50. Centers for Disease Control and Prevention. Drugresistant tuberculosis among the homeless— Boston. MMWR Morb Mortal Wkly Rep. 1985;34:429-431.
PUBMED
51. Riley RL, Nardell EA. Clearing the air: the theory and application of ultraviolet air disinfection. Am Rev Respir Dis. 1989;139:1286-1294.
PUBMED
52. Centers for Disease Control and Prevention. Guidelines for Prevention of TB Transmission in Hospitals. Atlanta, Ga: US Public Health Service; 1982. Publication CDC 82-8371. 53. Riley RL. Principles of UV Air Disinfection. Washington, DC: US Dept of Health, Education, and Welfare; 1972. Publication 00-2215. 54. Centers for Disease Control and Prevention. Prevention and control of tuberculosis in migrant farm workers: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1992;41(No. RR-10):1-15.
PUBMED
55. Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis— Boston. MMWR Morb Mortal Wkly Rep. 1993;42:1-8.
PUBMED
56. Iseman MD, Cohn DL, Sbarbaro JA. Directly observed treatment of tuberculosis. N Engl J Med. 1993;328:576-578.
FREE FULL TEXT
57. Cohn DL, Catlin BJ, Peterson KL, Judson FN, Sbarbaro JA. A 62 dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: a twice weekly, directly observed, and cost-effective regimen. Ann Intern Med. 1990;112:407-415.
FREE FULL TEXT
58. Combs DL, O'Brien RJ, Geiter LJ. USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity and acceptability: the report of final results. Ann Intern Med. 1990;112:397-406.
PUBMED
59. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA. 1993;270:65-68.
FREE FULL TEXT
60. Addington WW. Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States. Chest. 1979;76:741-743.
PUBMED
61. Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculous infection in high-risk populations: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1990;39:1-7.
PUBMED
62. Annas GJ. Control of tuberculosis: the law and the public's health. N Engl J Med. 1993;328:585-588.
FREE FULL TEXT
|